Dr. Gil Rabinovici is a professor of neurology at the University of California, San Francisco. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. G.D. Rabinovici. Controversy and Progress in Alzheimer’s Disease — FDA Approval of Aducanumab. N Engl J Med 2021;